Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sphingomyelin Phosphodiesterase | 2 | 2025 | 43 | 0.810 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 189 | 0.700 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2019 | 238 | 0.690 |
Why?
|
| Neointima | 2 | 2023 | 47 | 0.660 |
Why?
|
| Diet, High-Fat | 3 | 2024 | 255 | 0.640 |
Why?
|
| Sequestosome-1 Protein | 1 | 2018 | 15 | 0.600 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 486 | 0.560 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2023 | 129 | 0.550 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2019 | 192 | 0.540 |
Why?
|
| Inflammasomes | 3 | 2023 | 167 | 0.530 |
Why?
|
| Tight Junctions | 1 | 2016 | 40 | 0.510 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 145 | 0.470 |
Why?
|
| Autophagy | 1 | 2018 | 426 | 0.460 |
Why?
|
| Hyperglycemia | 1 | 2016 | 235 | 0.440 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2024 | 420 | 0.410 |
Why?
|
| Extracellular Vesicles | 2 | 2023 | 58 | 0.360 |
Why?
|
| Atherosclerosis | 1 | 2018 | 1006 | 0.340 |
Why?
|
| Acid Ceramidase | 2 | 2024 | 7 | 0.280 |
Why?
|
| Mice, Knockout | 5 | 2025 | 3868 | 0.250 |
Why?
|
| Coronary Vessels | 3 | 2021 | 549 | 0.240 |
Why?
|
| Niemann-Pick Diseases | 1 | 2025 | 4 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 4758 | 0.220 |
Why?
|
| Lysosomes | 1 | 2025 | 261 | 0.200 |
Why?
|
| Mice | 7 | 2025 | 18504 | 0.190 |
Why?
|
| Liver | 3 | 2024 | 1797 | 0.190 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 382 | 0.180 |
Why?
|
| Capillary Permeability | 1 | 2021 | 74 | 0.180 |
Why?
|
| Homeostasis | 1 | 2024 | 722 | 0.170 |
Why?
|
| Signal Transduction | 2 | 2025 | 4720 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 2442 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 18 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 423 | 0.150 |
Why?
|
| Myofibroblasts | 1 | 2018 | 64 | 0.140 |
Why?
|
| Animals | 7 | 2025 | 34842 | 0.140 |
Why?
|
| Endothelial Cells | 2 | 2023 | 526 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 898 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 333 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 540 | 0.130 |
Why?
|
| Streptozocin | 1 | 2016 | 26 | 0.130 |
Why?
|
| HMGB1 Protein | 1 | 2016 | 26 | 0.130 |
Why?
|
| Permeability | 1 | 2016 | 117 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 2018 | 443 | 0.120 |
Why?
|
| Cell Movement | 1 | 2019 | 890 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 436 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2021 | 915 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 689 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2019 | 3046 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 516 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4690 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2087 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2511 | 0.090 |
Why?
|
| Hepatocytes | 2 | 2024 | 239 | 0.090 |
Why?
|
| Cell Line | 1 | 2016 | 2724 | 0.090 |
Why?
|
| Phenotype | 1 | 2018 | 4538 | 0.070 |
Why?
|
| Male | 5 | 2025 | 64979 | 0.070 |
Why?
|
| Pericytes | 1 | 2025 | 23 | 0.060 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2024 | 126 | 0.050 |
Why?
|
| Ceramides | 1 | 2023 | 46 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2023 | 137 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 196 | 0.050 |
Why?
|
| Cell Extracts | 1 | 2021 | 13 | 0.050 |
Why?
|
| Microvessels | 1 | 2021 | 65 | 0.040 |
Why?
|
| Myocardium | 1 | 2025 | 907 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2025 | 652 | 0.040 |
Why?
|
| Humans | 3 | 2024 | 132199 | 0.040 |
Why?
|